top of page
HOME
HOME
A DIGITAL ACCESS SOLUTIONS COMPANY FOR HEALTHCARE
We provide digital data solutions that help unlock equitable access to medicines in five key European markets; France, Germany, Italy, Spain and the UK.
Our solutions provide unparalleled visibility of the access environment, giving pharma companies a meaningful benchmark for KPI management and helping them identify opportunities to improve access.
Anchor 1
Why You're Here
WE MAXIMISE THE VALUE OF MEDICINES
ValueBase is driven by a singular mission: to ensure all patients have timely access to the best treatments available, no matter where they live.
We partner with pharma companies to visualise the access environment and highlight disparities in target therapy areas. Our digital data solutions provide a unique evidence-base to inform strategies that maximise the value of medicines.
The world’s biggest pharma companies use ValueBase as their data insights partner – helping them design agile access strategies that support every stage of the product lifecycle, from early asset to loss of exclusivity.
Together we’re unlocking equitable access to medicines.
We specialise in digital data solutions that help pharma companies identify and manage barriers to access – allowing them to design strategies based on real-world indicators and meaningful analogues. We also partner with health providers and policymakers to highlight gaps in access that need addressing.
Our AI-led solutions can track the access environment in five key European markets – France, Germany, Italy, Spain and the UK – mapping access changes, whatever the levers steering regional access in each country. These may be formularies, guidelines or contracts. Insights can be combined with your latest prescribing data to give you critical insights around availability and impact.
SEE THE UNSEEABLE
How We Help
Anchor 2
Our Solutions
THE COMPLETE PICTURE. ALL DAY, EVERY DAY
Once coded, our digital access tools provide the complete picture of availability, access and adoption of medicines in five key European markets.
Our technology then monitors the market 24/7, allowing businesses to detect and respond to change as it happens or review trends over time.
Our solutions empower brand teams with real-world intelligence that drives competitive advantage – and helps unlock equitable access to medicines.
Anchor 6
Whre We Hep
Formulytics tracks medicines formularies all day, every day – detecting updates the day they happen.
It allows businesses to monitor product availability and adoption, benchmark competitors, identify early adopters and respond to gaps in access. Formulytics makes the invisible visible. Quickly and accurately.
In some countries, guidelines sit separately to formularies.
Guidelight can provide a real-time view of local guidelines. Once a therapy area is coded, it monitors the environment 24/7, capturing updates for every published guideline and every locality.
Our FOI system monitors updates to unpublished guidelines too, giving customers a 360° view of positioning, prescribing options and recommendations.
Our proprietary indexing tool, the Availability Index is a standard measure of access for every product that allows companies to compare the access availability of products within a locality and across regions.
It takes account of the initiating prescriber, the positioning and restrictions noted within the relevant access documents.
IF IT’S A QUESTION OF ACCESS, WE'LL HELP YOU FIND THE ANSWERS
Pharma companies use ValueBase to answer the big questions. Our solutions track the access environment over time, unlocking rich datasets that inform decision-making at every stage of the product lifecycle.
In-market multidisciplinary teams rely on our data insights to support:
• Commercial/brand strategy
• Business development
• Forecasting
• Product launch
• Strategy adjustment/refinement
• Loss of Exclusivity (LoE) planning
Click the buttons below to see some of the questions we can help you answer in 3 core areas:
Where We Help
Anchor 5
Our Tools
AUTOMATED INTELLIGENCE. ENGINEERED HERE.
ADA is our custom-designed artificial intelligence tool that works in the background of the business 24/7. ADA is programmed to look through millions of rows of UK formulary data and guidelines every day to flag changes for our data managers to investigate. Inspired by Ada Lovelace –who published the first known computer algorithm – she’s one of the team.
ANA is ADA’s twin sister –her focus is on formularies in markets outside the UK.
Our web scraping system for extracting published data from formularies/access sources. Designed in-house by our data engineers.
Built in-house, Humanae is web resource monitoring software for formulary information.
How We Do It
DIGITAL INGENUITY WITH THE HUMAN TOUCH
Public information on formularies and guidelines is disparate, variable and hard to find. The volume of change each day is vast. If you want to monitor the environment, you cannot do it manually. Digital is the only way.
Our AI-led solutions combine smart data engineering with the human touch. Systems are powered by tools designed in-house by our data engineers, using machine learning and automation to fuel better, quicker data management. Information is reviewed and cleansed by experts, then moved into data systems that fire our innovations.
It’s human and artificial intelligence combining to create actionable insight that helps unlock access to medicines.
Anchor 7
Anchor 8
Anchor 9
VALUE STORIES
Alzheimer’s patients face long wait to access breakthrough treatments in Europe
LATEST
September 2023
Not NICE: why are women being deprived access to life-changing cancer treatments?
ANALYSIS
March 2023
NICE-recommended lung cancer treatments still absent from formularies
ANALYSIS
August 2023
Access to medicines consistently fails to meet mandatory targets in the UK
ANALYSIS
July 2023
FEATURE
NICE - but not enough. Why evidence is better than assumption when executing your access strategy
Patients are being denied access to EAMS-listed medicines
ANALYSIS
February 2023
Head and neck cancer patients missing out on life-extending treatment
ANALYSIS
July 2023
PwC report exposes glaring disparities in UK healthcare
ANALYSIS
December 2022
FEATURE
Mapping at launch:
Time to update the satnav
Has Postcode Prescribing got its own category on NHS formularies?
ANALYSIS
April 2023
Endometrial cancer treatment granted EAMS status – but will patients get early access?
ANALYSIS
July 2023
Health inequity?
Let’s get it out of here
ANALYSIS
November 2022
VIDEO
Mastering the maze of UK formularies
FEATURE
Double your sales at launch? Here's how
ANALYSIS
A million patients with stroke, diabetes, asthma or kidney disease are missing out on approved medicines
VIDEO
Tracking formularies:
Five Top Tips
Our Values
PURPOSE-DRIVEN, VALUES-BASED
Why do we do it? That’s simple. We’re driven by a shared purpose:
To ensure medicines are available and accessible to all appropriate patients.
That’s your goal. It’s our goal too.
To achieve it, we adopt a values-based culture. Here are our values.
Anchor 10
Client-centred, Patient-first
We take every opportunity to delight our customers – and
our customers’ customers
Equitable
We advocate equitable access to opportunities (and medicines)
Collaborative and Agile
We work together in highly effective cross-functional and agile teams
Supportive
We look out for each other. We’re compassionate, empathetic and respectful
Flexible
We welcome and adapt to change and uncertainty
Scalable
We engender a growth mindset
Anchor 11
OUR MANAGEMENT TEAM
Karen Westaway
Chief Executive Officer
Caroline Shortland
Chief Operating Officer
Wilf Iliffe
Director of Analytics
Paula Baxter
Commercial Excellence Director
Robyn Nowers
Transformation Director
Chris Ross
Director of Content
CONTACT US
To find out how you could bolster your access strategy using ValueBase’s tools and analytics – or arrange a demonstration – get in touch.
Simply drop us a note using the web form right here.
Email us on enquiries@thevaluebase.com
Or connect with us on LinkedIn
Anchor 12
bottom of page